Yanxin Liu Selected Research

Yanxin Liu Research Topics

Disease

39	Neoplasms (Cancer) 10/2023 - 07/2004
9	Infections 08/2020 - 03/2005
6	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2005
4	Melanoma (Melanoma, Malignant) 08/2023 - 01/2022
4	Leukemia 01/2018 - 05/2004
4	Inflammation (Inflammations) 04/2015 - 01/2009
3	Keloid 07/2023 - 01/2023
3	Disease Progression 01/2023 - 11/2013
3	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2010
3	Lung Neoplasms (Lung Cancer) 01/2017 - 03/2005
3	Necrosis 02/2014 - 06/2008
2	Carcinogenesis 10/2023 - 02/2014
2	Thrombocytopenia (Thrombopenia) 07/2023 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 11/2022 - 01/2017
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2022 - 02/2011
2	Anemia 01/2022 - 01/2022
2	Fibrosis (Cirrhosis) 01/2018 - 01/2016
2	T-Cell Leukemia (Leukemia, T Cell) 03/2014 - 06/2009
2	HIV Infections (HIV Infection) 11/2013 - 04/2011
2	Hepatocellular Carcinoma (Hepatoma) 01/2008 - 07/2004
1	Esophageal Neoplasms (Esophageal Cancer) 10/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2023
1	Hemorrhage 10/2023
1	Hematuria 10/2023
1	Lymphatic Metastasis 11/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Dermatomyositis (Dermatopolymyositis) 01/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Wounds and Injuries (Trauma) 01/2022
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022
1	Obesity 01/2022
1	Ankylosing Spondylitis 01/2022
1	Nausea 01/2022
1	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 01/2022
1	Shock 01/2022
1	Ischemia 01/2022
1	Intestinal Obstruction (Obstruction, Intestinal) 01/2022
1	Psoriatic Arthritis 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Rupture 01/2022
1	Heart Failure 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022

Drug/Important Bio-Agent (IBA)

18	LigandsIBA 01/2017 - 07/2004
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017 - 07/2004
12	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
10	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2017 - 12/2006
7	Death Domain ReceptorsIBA 01/2017 - 03/2009
5	TNF-Related Apoptosis-Inducing LigandIBA 01/2017 - 08/2005
5	NF-kappa B (NF-kB)IBA 08/2009 - 07/2004
4	Monoclonal AntibodiesIBA 10/2023 - 05/2009
4	CytokinesIBA 01/2022 - 12/2005
3	MicroRNAs (MicroRNA)IBA 03/2016 - 12/2015
3	CaspasesIBA 08/2009 - 07/2004
2	pembrolizumabIBA 10/2023 - 01/2021
2	Long Noncoding RNAIBA 08/2023 - 01/2017
2	p38 Mitogen-Activated Protein KinasesIBA 07/2023 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2009
2	16S Ribosomal RNAIBA 11/2022 - 10/2022
2	olaparibIBA 01/2022 - 01/2022
2	Therapeutic UsesIBA 01/2021 - 02/2011
2	ChemokinesIBA 02/2014 - 01/2009
2	Epirubicin (Ellence)FDA LinkGeneric 09/2012 - 05/2012
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2011 - 08/2009
2	CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)IBA 04/2011 - 05/2009
2	ProteomeIBA 01/2009 - 03/2005
2	Fluorouracil (Carac)FDA LinkGeneric 06/2008 - 05/2004
2	Culture MediaIBA 12/2005 - 08/2005
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 10/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2023
1	Bevacizumab (Avastin)FDA Link 10/2023
1	Transforming Growth Factor-beta Type I ReceptorIBA 08/2023
1	Linezolid (Zyvox)FDA Link 07/2023
1	Sincalide FDA Link 07/2023
1	osteoadherinIBA 07/2023
1	SphingolipidsIBA 01/2023
1	CollagenIBA 01/2023
1	GlycosphingolipidsIBA 01/2023
1	condensin complexes (condensin)IBA 12/2022
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2022
1	DiureticsIBA 01/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022
1	CreatinineIBA 01/2022
1	semaglutideIBA 01/2022
1	Insulin-Like PeptidesIBA 01/2022
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	secukinumabIBA 01/2022
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2022
1	VemurafenibIBA 01/2022
1	osimertinibIBA 01/2022
1	Moxifloxacin (Avelox)FDA Link 01/2022
1	Messenger RNA (mRNA)IBA 01/2022

Therapy/Procedure

23	Therapeutics 10/2023 - 03/2005
4	Immunotherapy 01/2021 - 12/2005
2	Drug Therapy (Chemotherapy) 11/2022 - 09/2012
1	Radiotherapy 10/2023